Timothy P. Kelly, Chief Operating Officer at Homology Medicines, Inc. (FIXX), sold 1,406 shares at $3.78 ($5K) on 2022-01-05, disclosed to the SEC on 2022-01-12.
Scheduled sale ($5k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FIXX | SELL | 2021-09-08 | $416 | — | Filing → |
| FIXX | SELL | 2021-03-03 | $139K | — | Filing → |
| FIXX | SELL | 2021-02-05 | $7K | — | Filing → |